| 11655225 |
Antimycobacterial heterocyclic amides |
Joshua Day, James Graham, Elizabeth A. McFaddin, Urs Ochsner, Xicheng Sun +1 more |
2023-05-23 |
|
| 11221340 |
Lung cancer biomarkers and uses thereof |
Sheri K. Wilcox, Deborah Ayers, Nebojsa Janjic, Larry Gold, Michael Riel-Mehan |
2022-01-11 |
$21,613,000 |
| 11208663 |
Post-selex modification methods |
John C. Rohloff, Amy D. Gelinas, Chi Zhang, Daniel W. Drolet, Sheela M. Waugh +1 more |
2021-12-28 |
$25,745,000 |
| 10221421 |
Post-selec modification methods |
John C. Rohloff, Amy D. Gelinas, Chi Zhang, Daniel W. Drolet, Sheela M. Waugh +1 more |
2019-03-05 |
|
| 9701967 |
Aptamers to PDGF and VEGF and their use in treating PDGF and VEGF mediated conditions |
John C. Rohloff, Amy D. Gelinas, Chi Zhang, Daniel W. Drolet, Sheela M. Waugh +1 more |
2017-07-11 |
|
| 9410156 |
Aptamers to PDGF and VEGF and their use in treating PDGF and VEGF mediated conditions |
John C. Rohloff, Amy D. Gelinas, Chi Zhang, Daniel W. Drolet, Sheela M. Waugh +1 more |
2016-08-09 |
|
| 9382533 |
Method for generating aptamers with improved off-rates |
Dominic Zichi, Sheri K. Wilcox, Chris Bock, Daniel J. Schneider, Bruce Eaton +2 more |
2016-07-05 |
|
| 9206429 |
Aptamers that bind to IL-6 and their use in treating or diagnosing IL-6 mediated conditions |
Shashi Gupta, Masao Hirota, Daniel J. Schneider, Tomoki Suzuki, Yuichi Ishikawa +4 more |
2015-12-08 |
|
| 8975026 |
Method for generating aptamers with improved off-rates |
Dominic Zichi, Sheri K. Wilcox, Chris Bock, Daniel J. Schneider, Bruce Eaton +2 more |
2015-03-10 |
|
| 8716320 |
Antibacteriall heterocyclic ureas |
Joseph Guiles, Sarah Strong, Xicheng Sun |
2014-05-06 |
$9,387,000 |
| 8431376 |
Bacterial replication systems and methods |
Charles S. McHenry, Nebojsa Janjic, Garry Dallmann, James M. Bullard, Stacie Bell +2 more |
2013-04-30 |
|
| 8293919 |
Antibacterial sulfone and sulfoxide substituted heterocyclic urea compounds |
Joseph Guiles, Sarah Strong, Xicheng Sun, Jian Qiu, John C. Rohloff |
2012-10-23 |
|
| 8148380 |
Antibacterial amide and sulfonamide substituted heterocyclic urea compounds |
Joseph Guiles, Sarah Strong, Xicheng Sun, Jian Qiu, John C. Rohloff |
2012-04-03 |
|
| 6673611 |
Nucleic acid molecules with novel chemical compositions capable of modulating gene expression |
James D. Thompson, Leonid Beigelman, James McSwiggen, Alexander Karpeisky, Laurent Bellon +5 more |
2004-01-06 |
$2,800,000 |
| 6586238 |
Enzymatic nucleic acids containing 5′-and or 3′-cap structures |
Jasenka Matulic-Adamic, Leonid Beigelman, Alexander Karpeisky, Nassim Usman, Anthony DiRenzo +1 more |
2003-07-01 |
$9,935,000 |
| 6214621 |
Conjugates of a particle vector and oligonucleotides, process for their preparation, and pharmaceutical compositions containing them |
Didier Betbeder, Roger Kravtzoff, Ignacio De Miguel, Sophie Sixou, Pamela Pavco |
2001-04-10 |
|
| 6194150 |
Nucleic acid based inhibition of CD40 |
Dan T. Stinchcomb, James McSwiggen |
2001-02-27 |
$4,087,000 |
| 6103890 |
Enzymatic nucleic acids that cleave C-fos |
James McSwiggen, Dan T. Stinchcomb |
2000-08-15 |
$12,815,000 |
| 5998203 |
Enzymatic nucleic acids containing 5'-and/or 3'-cap structures |
Jasenka Matulic-Adamic, Leonid Beigelman, Alexander Karpeisky, Nassim Usman, Anthony DiRenzo +1 more |
1999-12-07 |
$1,709,000 |
| 5877021 |
B7-1 targeted ribozymes |
Dan T. Stinchcomb, James McSwiggen |
1999-03-02 |
$1,074,000 |
| 5817796 |
C-myb ribozymes having 2'-5'-linked adenylate residues |
Dan T. Stinchcomb, Kenneth G. Draper, James McSwiggen |
1998-10-06 |
|
| 5646042 |
C-myb targeted ribozymes |
Dan T. Stinchcomb, Kenneth G. Draper, James McSwiggen |
1997-07-08 |
$544,000 |